Adenosine Compounds
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
415
NCT04726371
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
Phase: N/A
Role: Collaborator
Start: Nov 1, 2020
Completion: Nov 30, 2022
Loading map...